Recent Blog Postings
- UPDATE: Kezar Life Sciences Terminates Phase 2b Study of Zetomipzomib for Lupus Nephritis Treatment
- UPDATE: FDA Grants Cullinan Therapeutics Clearance for Application to Investigate CLN-978 for the Treatment of Systemic Lupus Erythematosus, Phase I Trial to Begin Soon
- Celebrating Hispanic Heritage Month 2024: Addressing Lupus in the Hispanic Community